TABLE 1.
Comparison of clinical characteristics between the COVID‐19 group and the control group
| COVID‐19 group (n = 16) | Control group (n = 24) | p value | |
|---|---|---|---|
| Sex (M/F) | 12/4 | 17/7 | >.99 |
| Age (years) | 60.4 ± 2.7 | 68.2 ± 2.5 | .047 |
| Body mass index | 24.9 ± 1.0 | 23.5 ± 2.0 | .07 |
| Prone positioning (n, %) | 16 (100%) | 1 (4.2%) | <.001 |
| Hypertension (n, %) | 4 (25.0%) | 12 (50.0%) | .19 |
| Hyperlipidemia (n, %) | 1 (6.3%) | 3 (12.5%) | .64 |
| Diabetes mellitus (n, %) | 4 (25.0%) | 14 (58.3%) | .05 |
| Duration of endotracheal intubation (days) | 9.6 ± 0.8 | 10.8 ± 1.0 | .72 |
| Duration from extubation to laryngeal evaluation (days) | 12.4 ± 3.6 | 10.0 ± 2.0 | .99 |
| Unilateral vocal fold immobility (n, %) | 5 (31.3%) | 1 (4.2%) | .03 |
| Laryngeal granuloma (n, %) | 5 (31.3%) | 1 (4.2%) | .03 |
Note: M, male; F, female.